全文获取类型
收费全文 | 90608篇 |
免费 | 42960篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 1594篇 |
儿科学 | 4563篇 |
妇产科学 | 763篇 |
基础医学 | 17377篇 |
口腔科学 | 5312篇 |
临床医学 | 14469篇 |
内科学 | 23955篇 |
皮肤病学 | 7608篇 |
神经病学 | 14685篇 |
特种医学 | 2794篇 |
外国民族医学 | 1篇 |
外科学 | 16078篇 |
综合类 | 224篇 |
一般理论 | 49篇 |
预防医学 | 6553篇 |
眼科学 | 1622篇 |
药学 | 6816篇 |
中国医学 | 1033篇 |
肿瘤学 | 8127篇 |
出版年
2023年 | 137篇 |
2022年 | 91篇 |
2021年 | 1584篇 |
2020年 | 5290篇 |
2019年 | 11166篇 |
2018年 | 10460篇 |
2017年 | 11748篇 |
2016年 | 12274篇 |
2015年 | 12208篇 |
2014年 | 12268篇 |
2013年 | 12964篇 |
2012年 | 5428篇 |
2011年 | 5339篇 |
2010年 | 9560篇 |
2009年 | 5886篇 |
2008年 | 3207篇 |
2007年 | 2208篇 |
2006年 | 2090篇 |
2005年 | 1881篇 |
2004年 | 1869篇 |
2003年 | 1794篇 |
2002年 | 1649篇 |
2001年 | 650篇 |
2000年 | 447篇 |
1999年 | 187篇 |
1998年 | 213篇 |
1997年 | 140篇 |
1996年 | 108篇 |
1995年 | 105篇 |
1994年 | 117篇 |
1993年 | 90篇 |
1992年 | 55篇 |
1991年 | 47篇 |
1990年 | 34篇 |
1989年 | 36篇 |
1988年 | 27篇 |
1987年 | 34篇 |
1986年 | 24篇 |
1985年 | 24篇 |
1984年 | 25篇 |
1983年 | 29篇 |
1982年 | 24篇 |
1981年 | 26篇 |
1980年 | 20篇 |
1979年 | 6篇 |
1978年 | 11篇 |
1977年 | 8篇 |
1976年 | 13篇 |
1975年 | 3篇 |
1961年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Tolley Elizabeth E. Hamilton Erica L. Eley Natalie Maragh-Bass Allysha C. Okumu Eunice Balán Iván C. Gamble Theresa Beyrer Chris Remien Robert 《AIDS and behavior》2022,26(9):3119-3130
AIDS and Behavior - Adherence to care and antiretroviral therapy is challenging, especially for people living with HIV (PLWH) with additional co-occurring risk factors. Case management... 相似文献
2.
3.
4.
Ccile Toly‐Ndour Stphanie Huguet‐Jacquot Agns Mailloux Hlne Delaby Giorgia Canellini Martin L. Olsson Agneta Wikman Joke M. Koelewijn Jean‐Marc Minon Tobias J. Legler Frederik B. Clausen Mark Lambert Helen Ryan Irena Bricl Sys Hasslund Agnieszka Orzinska Katarzyna Guz Malgorzata Uhrynowska Antonella Matteocci Nuria Nogues Eduardo Muniz‐Diaz Susanna Sainio Masja De Haas C. Ellen Van der Schoot 《ISBT科学丛刊》2021,16(1):106-118
5.
6.
7.
Sara García‐Oreja Francisco Javier lvaro‐Afonso Yolanda García‐lvarez Esther García‐Morales Irene Sanz‐Corbaln Jose Luis Lzaro Martínez 《Dermatologic therapy》2021,34(1):e14621
There are a wide variety of treatments for plantar warts, but none has been shown to be effective in all patients. We aimed to perform a systematic review of the efficacy of different topical treatments on plantar warts. Systematic electronic searches (Pubmed, Cochrane Library, Embase, and Web of Science) were conducted in April 2020. Meta‐analyses, systematic reviews, and retrospective or prospective clinical trials of the effects of topical and nonsurgical treatments of plantar warts were included. Two authors performed the study selection and data extraction. Any discrepancies between the two reviewers were discussed with a third reviewer. Forty‐four studies were included. The average cure rates of the most frequent treatments were variable across the studies: cryotherapy (45.61%), salicylic acid (13.6%), cantharidin‐podophyllin‐salicylic acid formulation (97.82%), laser (79.36%), topical antivirals (72.45%), intralesional bleomycin (83.37%), and intralesional immunotherapy (68.14%). Twenty‐two studies (50%) had a level of evidence 1b and grade of recommendation A, five studies (11.4%) had a level of evidence 2b and grade of recommendation B, two studies (4.5%) had a level of evidence 3b and grade of recommendation B, and 15 studies (34,1%) with a level of evidence 4 and grade of recommendation C. First‐choice treatments for common warts, such as cryotherapy and salicylic acid, have low‐cure rates for plantar warts. Other treatments, such as CPA formulation, immunotherapy, and intralesional bleomycin, which have compassionate use, have higher cure rates. This review should stimulate future high‐quality research to evaluate these specialized treatments. 相似文献
8.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
9.
Daniel Reis Waisberg Edson Abdala Lucas Souto Nacif Luciana Bertocco Haddad Liliana Ducatti Vinicius Rocha Santos Larissa Nunes Gouveia Carolina Santos Lazari Rodrigo Bronze Martino Rafael Soares Pinheiro Rubens Macedo Arantes Debora Raquel Terrabuio Luiz Marcelo Malbouisson Flavio Henrique Galvao Wellington Andraus Luiz Augusto Carneiro‐D'Albuquerque 《Transplant infectious disease》2021,23(1):e13418
The impact of coronavirus disease‐19 (COVID‐19) in liver recipients remains largely unknown. Most data derive from small retrospective series of patients transplanted years ago. We aimed to report a single‐center case series of five consecutive patients in the early postoperative period of deceased‐donor liver transplantation who developed nosocomial COVID‐19. Two patients presented important respiratory discomfort and eventually died. One was 69 years old and had severe coronary disease. She rapidly worsened after COVID‐19 diagnosis on 9th postoperative day. The other was 67 years old with non‐alcoholic steatohepatitis, who experienced prolonged postoperative course, complicated with cytomegalovirus infection and kidney failure. He was diagnosed on 36th postoperative day and remained on mechanical ventilation for 20 days, ultimately succumbing of secondary bacterial infection. The third, fourth, and fifth patients were diagnosed on 10th, 11th, and 18th postoperative day, respectively, and presented satisfactory clinical evolution. These last two patients were severely immunosuppressed, since one underwent steroid bolus for acute cellular rejection and another also used anti‐thymocyte globulin for treating steroid‐resistant rejection. Our novel experience highlights that COVID‐19 may negatively impact the postoperative course, especially in elder and obese patients with comorbidities, and draws attention to COVID‐19 nosocomial spread in the early postoperative period. 相似文献